3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
aldesleukin
15
Cyclophosphamide
15
fludarabine phosphate
12
fludarabine
11
Interleukin-2
10
Nivolumab
6
Ipilimumab
6
Temozolomide
5
pembrolizumab
3
Fluorouracil
3
trametinib
2
sonidegib
2
dabrafenib
2
binimetinib
2
Whole-Body Irradiation
2
Vemurafenib
2
Tacrolimus
2
Sodium Chloride
2
Sirolimus
2
Radiotherapy
2
Radiation
2
Peptides
2
HhAntag691
2
Gefitinib
2
Dacarbazine
2
Cyclosporine
2
Cetuximab
2
Capecitabine
2
veliparib
1
varlilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Skin Neoplasms
×
Imatinib Mesylate
×
Clear all
No trials found.